142 related articles for article (PubMed ID: 23867014)
21. Co-administration of certain DNA vaccine combinations expressing different H5N1 influenza virus antigens can be beneficial or detrimental to immune protection.
Patel A; Gray M; Li Y; Kobasa D; Yao X; Kobinger GP
Vaccine; 2012 Jan; 30(3):626-36. PubMed ID: 22119588
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of conserved and variable influenza antigens for immunization against different isolates of H5N1 viruses.
Patel A; Tran K; Gray M; Li Y; Ao Z; Yao X; Kobasa D; Kobinger GP
Vaccine; 2009 May; 27(23):3083-9. PubMed ID: 19428922
[TBL] [Abstract][Full Text] [Related]
23. Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization.
Gao W; Soloff AC; Lu X; Montecalvo A; Nguyen DC; Matsuoka Y; Robbins PD; Swayne DE; Donis RO; Katz JM; Barratt-Boyes SM; Gambotto A
J Virol; 2006 Feb; 80(4):1959-64. PubMed ID: 16439551
[TBL] [Abstract][Full Text] [Related]
24. An aptamer that binds efficiently to the hemagglutinins of highly pathogenic avian influenza viruses (H5N1 and H7N7) and inhibits hemagglutinin-glycan interactions.
Suenaga E; Kumar PK
Acta Biomater; 2014 Mar; 10(3):1314-23. PubMed ID: 24374323
[TBL] [Abstract][Full Text] [Related]
25. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
Jadhao SJ; Lee CW; Sylte M; Suarez DL
Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
[TBL] [Abstract][Full Text] [Related]
26. [Construction of bicistronic eukaryotic expression vector containing HA and M2 genes derived from high pathogenic avian influenza virus (HPAI) H5N1 (Anhui strain)and its efficient expression in mammalian cells].
Liu Y; Zhang K; Tan WJ; Wang HJ; Shu YL; Hu GX; Ruan L
Bing Du Xue Bao; 2008 Nov; 24(6):415-20. PubMed ID: 19226948
[TBL] [Abstract][Full Text] [Related]
27. Expression and purification of bioactive hemagglutinin protein of highly pathogenic avian influenza A (H5N1) in silkworm larvae.
Dong J; Harada M; Yoshida S; Kato Y; Murakawa A; Ogata M; Kato T; Usui T; Park EY
J Virol Methods; 2013 Dec; 194(1-2):271-6. PubMed ID: 24041500
[TBL] [Abstract][Full Text] [Related]
28. Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine.
Baras B; Stittelaar KJ; Simon JH; Thoolen RJ; Mossman SP; Pistoor FH; van Amerongen G; Wettendorff MA; Hanon E; Osterhaus AD
PLoS One; 2008 Jan; 3(1):e1401. PubMed ID: 18167560
[TBL] [Abstract][Full Text] [Related]
29. Recombinant modified vaccinia virus Ankara expressing the hemagglutinin gene confers protection against homologous and heterologous H5N1 influenza virus infections in macaques.
Kreijtz JH; Suezer Y; de Mutsert G; van den Brand JM; van Amerongen G; Schnierle BS; Kuiken T; Fouchier RA; Löwer J; Osterhaus AD; Sutter G; Rimmelzwaan GF
J Infect Dis; 2009 Feb; 199(3):405-13. PubMed ID: 19061423
[TBL] [Abstract][Full Text] [Related]
30. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses.
Li S; Liu C; Klimov A; Subbarao K; Perdue ML; Mo D; Ji Y; Woods L; Hietala S; Bryant M
J Infect Dis; 1999 May; 179(5):1132-8. PubMed ID: 10191214
[TBL] [Abstract][Full Text] [Related]
31. Safety and immunogenicity of a vero cell culture-derived whole-virus influenza A(H5N1) vaccine in a pediatric population.
van der Velden MV; Fritz R; Pöllabauer EM; Portsmouth D; Howard MK; Kreil TR; Dvorak T; Fritsch S; Vesikari T; Diez-Domingo J; Richmond P; Lee BW; Kistner O; Ehrlich HJ; Barrett PN; Aichinger G
J Infect Dis; 2014 Jan; 209(1):12-23. PubMed ID: 24041789
[TBL] [Abstract][Full Text] [Related]
32. Improved haemagglutinin antigen content in H5N1 candidate vaccine viruses with chimeric haemagglutinin molecules.
Harvey R; Nicolson C; Johnson RE; Guilfoyle KA; Major DL; Robertson JS; Engelhardt OG
Vaccine; 2010 Nov; 28(50):8008-14. PubMed ID: 20934460
[TBL] [Abstract][Full Text] [Related]
33. Reverse engineering the antigenic architecture of the haemagglutinin from influenza H5N1 clade 1 and 2.2 viruses with fine epitope mapping using monoclonal antibodies.
Rockman S; Camuglia S; Vandenberg K; Ong C; Baker MA; Nation RL; Li J; Velkov T
Mol Immunol; 2013 Apr; 53(4):435-42. PubMed ID: 23127859
[TBL] [Abstract][Full Text] [Related]
34. Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010.
; Ampofo WK; Baylor N; Cobey S; Cox NJ; Daves S; Edwards S; Ferguson N; Grohmann G; Hay A; Katz J; Kullabutr K; Lambert L; Levandowski R; Mishra AC; Monto A; Siqueira M; Tashiro M; Waddell AL; Wairagkar N; Wood J; Zambon M; Zhang W
Influenza Other Respir Viruses; 2012 Mar; 6(2):142-52, e1-5. PubMed ID: 21819547
[TBL] [Abstract][Full Text] [Related]
35. H5N1 influenza marker vaccine for serological differentiation between vaccinated and infected chickens.
Li C; Ping J; Jing B; Deng G; Jiang Y; Li Y; Tian G; Yu K; Bu Z; Chen H
Biochem Biophys Res Commun; 2008 Jul; 372(2):293-7. PubMed ID: 18501701
[TBL] [Abstract][Full Text] [Related]
36. [Immunological evaluation of vector-expressed M2 and HA genes of H5N1 influenza virus in mice].
Guo J; Yao L; Chen A; Xu Y; Liu X; Shu Y; Zhang Z
Sheng Wu Gong Cheng Xue Bao; 2010 May; 26(5):649-56. PubMed ID: 20684310
[TBL] [Abstract][Full Text] [Related]
37. Application of deglycosylation and electrophoresis to the quantification of influenza viral hemagglutinins facilitating the production of 2009 pandemic influenza (H1N1) vaccines at multiple manufacturing sites in China.
Li C; Shao M; Cui X; Song Y; Li J; Yuan L; Fang H; Liang Z; Cyr TD; Li F; Li X; Wang J
Biologicals; 2010 Mar; 38(2):284-9. PubMed ID: 20074976
[TBL] [Abstract][Full Text] [Related]
38. Identification of Influenza A/PR/8/34 Donor Viruses Imparting High Hemagglutinin Yields to Candidate Vaccine Viruses in Eggs.
Johnson A; Chen LM; Winne E; Santana W; Metcalfe MG; Mateu-Petit G; Ridenour C; Hossain MJ; Villanueva J; Zaki SR; Williams TL; Cox NJ; Barr JR; Donis RO
PLoS One; 2015; 10(6):e0128982. PubMed ID: 26068666
[TBL] [Abstract][Full Text] [Related]
39. HA1 (Hemagglutinin) quantitation for influenza A H1N1 and H3N2 high yield reassortant vaccine candidate seed viruses by RP-UPLC.
Fulvini AA; Tuteja A; Le J; Pokorny BA; Silverman J; Bucher D
Vaccine; 2021 Jan; 39(3):545-553. PubMed ID: 33341306
[TBL] [Abstract][Full Text] [Related]
40. Enhanced growth of seed viruses for H5N1 influenza vaccines.
Horimoto T; Murakami S; Muramoto Y; Yamada S; Fujii K; Kiso M; Iwatsuki-Horimoto K; Kino Y; Kawaoka Y
Virology; 2007 Sep; 366(1):23-7. PubMed ID: 17651774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
